Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Quality Index
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Quality Index of 1.48x as of September 2025. Operating cash flow of CN¥174.36 Million exceeds net income of CN¥117.90 Million, indicating high earnings quality where cash backs reported profits. Explore 688526 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Keqian Biology Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688526 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Wuhan Keqian Biology Co Ltd. For live market cap and the full company financial profile, see market cap of Wuhan Keqian Biology Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.03x | CN¥392.68 Million | CN¥381.49 Million | ▼ -24.3% |
| 2023 | 1.36x | CN¥538.03 Million | CN¥395.93 Million | ▲ +31.2% |
| 2022 | 1.04x | CN¥423.71 Million | CN¥409.15 Million | ▲ +11.2% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥570.64 Million | ▲ +4.2% |
| 2020 | 0.89x | CN¥400.14 Million | CN¥447.80 Million | ▲ +40.0% |
| 2019 | 0.64x | CN¥154.89 Million | CN¥242.64 Million | ▼ -29.4% |
| 2018 | 0.90x | CN¥351.83 Million | CN¥388.91 Million | ▼ -14.2% |
| 2017 | 1.05x | CN¥337.61 Million | CN¥320.31 Million | ▼ -11.1% |
| 2016 | 1.19x | CN¥220.69 Million | CN¥186.17 Million | — |